INTRODUCTION ABOUT VOGLIWAL 0.3MG TABLET
VOGLIWAL 0.3MG TABLET is used in the management of type 2 diabetes mellitus along with diet and exercise to improve post-prandial blood glucose levels (when only diet and/or exercise or oral hypoglycemic drugs or insulin preparation in addition to diet and/or exercise does not result in adequate glycemic control). It contains Voglibose which belongs to the group of medicines called Anti-diabetics. It works by inhibiting the intestinal enzymes that are responsible for breaking complex sugars into simple sugars such as glucose. This manages the level of blood glucose from increasing very high immediately after meals.
Along management with VOGLIWAL 0.3MG TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. VOGLIWAL 0.3MG TABLET is not recommended for use in patients having severe ketosis, severe infection, before and after an operation, or with serious trauma and gastrointestinal obstruction.
VOGLIWAL 0.3MG TABLET should be used with caution in patients undergoing abdominal laparotomy for gallstone ileus or have roemheld’s syndrome, stenosis, liver, and kidney problems and in elderly patients. VOGLIWAL 0.3MG TABLET is not recommended for use among pregnant, breastfeeding women, children, and adolescents. The most common side effects of taking VOGLIWAL 0.3MG TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your doctor if any of the above symptoms worsen.
USES OF VOGLIWAL 0.3MG TABLET
- Used to manage type 2 diabetes mellitus along with diet and exercise
HOW VOGLIWAL 0.3MG TABLET WORKS
VOGLIWAL 0.3MG TABLET works by inhibiting the intestinal enzymes that are responsible for breaking complex sugars into simple sugars such as glucose. This manages the level of blood glucose from increasing very high immediately after meals.
DIRECTIONS FOR USE
- Take VOGLIWAL 0.3MG TABLET as advised by your physician
- For Tablet: Swallow the medicine with a glass of water. Do not crush or chew the medicine
- For Mouth Dissolving Tablet: Let the tablet dissolve in your mouth. There is no need to chew or swallow it with water. It will typically dissolve within a few seconds to a minute.
- Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition
- Continue to take the medicine for the stipulated duration prescribed by your doctor to achieve better results
SIDE EFFECTS OF VOGLIWAL 0.3MG TABLET
Common side effects of VOGLIWAL 0.3MG TABLET:
- soft stools or diarrhea
- flatulence, abdominal pain or discomfort
Stop taking VOGLIWAL 0.3MG TABLET and contact your physician immediately if you experience any of the following side effects:
- signs of hypersensitivity reactions (severe skin rash with itching)
WARNING & PRECAUTIONS
PREGNANCY
Monitoring requiredVOGLIWAL 0.3MG TABLET should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
BREASTFEEDING
ContraindicatedVOGLIWAL 0.3MG TABLET is not recommended for use in breastfeeding women as it may passes through breast milk.
KIDNEY
Use with CautionVOGLIWAL 0.3MG TABLET should be taken with caution in patients with kidney problems.
LIVER
Use with CautionVOGLIWAL 0.3MG TABLET should be taken with caution in patients with liver problems.
ALLERGY
ContraindicatedDo not take VOGLIWAL 0.3MG TABLET if you are allergic to Voglibose or any ingredients of this medicine.
USE IN PEDIATRICS
Consult your doctorThe safety of VOGLIWAL 0.3MG TABLET in children has not been established.
USE IN GERIATRICS
Use with CautionVOGLIWAL 0.3MG TABLET should be used with caution in elderly patients.
OTHERS
VOGLIWAL 0.3MG TABLET is not recommended for use if you have:
- severe ketosis
- severe infection, after and before an operation
- serious trauma
- gastrointestinal obstruction
Before taking VOGLIWAL 0.3MG TABLET, inform your physician if you:
- are undergoing abdominal laparotomy for gallstone ileus
- have roemheld’s syndrome (cluster of cardiovascular symptoms stimulated by gastrointestinal changes)
- have stenosis (condition in which there is an abnormal narrowing in a blood vessel or other tubular organ or structure such as foramina and canals)
INTERACTIONS
A. Drug-Drug interactions:
Before taking VOGLIWAL 0.3MG TABLET, inform your physician if you are taking any of the following medicines:
- Antidiabetics (Ex. glipizide, tolbutamide, insulin) (used to manage diabetes)
- Beta blockers (Ex. metoprolol, atenolol)
- Keratolytics (Ex. salicylic acid)
- Monoamine oxidase inhibitors (MAOIs) (Ex. phenelzine, selegiline)
- Anti-lipedmic agents (Ex. fenofibrate)
- Sympathomimetics or adrenergic agonists (Ex. epinephrine)
- Adrenocorticotropic hormones (Ex. adrenocorticotrophin)
- Hormones (Ex. thyroxine)
Overdosage:
If you or anyone else accidentally takes too much of VOGLIWAL 0.3MG TABLET, consult your physician immediately or visit the nearby hospital. Symptoms of overdosage are low blood sugar levels, abdominal discomfort and diarrhea.
SYNOPSIS
| Drug | : | Voglibose |
| Pharmacological Category | : | Alpha Glucosidase inhibitors |
| Therapeutic Indication | : | Type 2 diabetes mellitus |
| Dosage Forms | : | Tablet |
MORE INFORMATION
FAQs ABOUT VOGLIWAL 0.3MG TABLET
Q: Can VOGLIWAL 0.3MG TABLET cause diarrhea?
A: Diarrhea is the common side-effect of VOGLIWAL 0.3MG TABLET. Drink more fluids, such as water or fruit juice to keep yourself hydrated. Do not take any medicine on your own to manage diarrhea without consulting your physician.
Q: Who should not take VOGLIWAL 0.3MG TABLET?
A: VOGLIWAL 0.3MG TABLET is not recommended for use in patients having severe ketosis, in a state of diabetic coma, severe infection, before and after an operation, or with serious trauma and gastrointestinal obstruction.
Q: What if I forget to take a dose of VOGLIWAL 0.3MG TABLET?
A: You should take VOGLIWAL 0.3MG TABLET immediately when you remember. If it is time for your next dose skip missed the dose and follow your regular dose schedule. Do not double the dose to match up your missed dose.
Q: How to take VOGLIWAL 0.3MG TABLET?
A: Take VOGLIWAL 0.3MG TABLET as advised by your physician. Your physician will decide the correct dose and duration for you depending upon your age, body weight, and disease condition.
Q: What are the common side effects of VOGLIWAL 0.3MG TABLET?
A: The most common side effects of taking VOGLIWAL 0.3MG TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your physician if any of the symptoms worsen.
Q: What happens when I take an overdose of VOGLIWAL 0.3MG TABLET?
A: If you or anyone else accidentally take too much of VOGLIWAL 0.3MG TABLET, consult your physician immediately or visit the nearby hospital. The symptoms of overdosage are low blood sugar levels, abdominal discomfort, and diarrhea.
REFERENCES
1. Alvin C. Powers and David D’Alessio. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 13th Edition. New York McGraw Hill Medical 2018. Page – 863-886.
2. KD. Tripathi. Insulin, Oral Hypoglycemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page – 258-281.
3. Ajay S. Dabhi, Nikita R. Bhatt, and Mohit J. Shah. Voglibose: An Alpha Glucosidase Inhibitor. Journal of Clinical and Diagnostic Research. December 2013 [Accessed on 21st June 2022] click here
4. Sanjay Kalra, A Panneer Selvam, Amish V Shah, Kudugunti Neelaveni, Navneet Agrawal, Sambit Das, Vinay K Dhandhania, Subodh Jain, Pankaj Kumar Jha and Neha Rava. Prospective Multicenter Observational Study of Voglibose in Type 2 Diabetes-Victory. Journal of US Endocrinology. January 2020 [Accessed on 21st June 2022] click here
5. Cipla Ltd. Prandal MD Tablets (Voglibose). Ciplamed. [Revised in August 2015] [Accessed on 21st June 2022] click here
6. Amigoz life sciences. Voglibose Tablets. [Accessed on 21st June 2022] click here
7. DM Pharma. Voglibose Tablet. Antidiabetic agents. [Accessed on 21st June 2022] click here
AUTHOR DETAILS
